Probable Zika virus-associated Guillain-Barré syndrome: Challenges with clinico-laboratory diagnosis

Journal of the Neurological Sciences

Volumn 375, Issue , 2017, Pages 367-370

  Miller, Eliza ^a   Becker, Zoe ^b   Shalev, Daniel ^a   Lee, Christopher T ^c,d   Cioroiu, Comana ^a   Thakur, Kiran ^a  

^a NewYork Presbyterian Hospital   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Flavivirus; Guillain Barr syndrome; Zika virus

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS RNA;

ADULT; ANTIBODY TITER; AREFLEXIA; ARTICLE; ATAXIA; BACKACHE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DENGUE VIRUS; DOMINICAN REPUBLIC; DYSMETRIA; EMERGENCY WARD; FATIGUE; FEMALE; GAIT DISORDER; GUILLAIN BARRE SYNDROME; HEARING IMPAIRMENT; HOSPITAL ADMISSION; HUMAN; HYPERESTHESIA; HYPOGEUSIA; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY DIAGNOSIS; LEG PAIN; LUMBAR PUNCTURE; MALAISE; MIDDLE AGED; NERVE CONDUCTION; NEUROLOGIC DISEASE; NEW YORK; NONHUMAN; PARESTHESIA; PLAQUE REDUCTION NEUTRALIZATION TESTING; PLEOCYTOSIS; PRIORITY JOURNAL; PROPRIOCEPTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN TINGLING; TASTE DISORDER; TREATMENT DURATION; UNSTEADINESS; VIBRATION; WEAKNESS; ZIKA FEVER; ZIKA VIRUS; COMPLICATION; GUILLAIN-BARRE SYNDROME; PATHOGENICITY; VIROLOGY;

FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; MIDDLE AGED; NEW YORK CITY; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85013653092     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2017.02.029     Document Type: Article

References (18)

1. [1] Sejvar, J.J., Kohl, K.S., Gidudu, J., Amato, A., Bakshi, N., Baxter, R., et al. Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29 (2011), 599–612, 10.1016/j.vaccine.2010.06.003.
2. [2] Rabe, I.B., Staples, J.E., Villanueva, J., Hummel, K.B., Johnson, J.A., Rose, L., et al. Interim guidance for interpretation of Zika virus antibody test results. Morbidity and Mortality Weekly Report, 65, 2016 http://www.cdc.gov/mmwr/volumes/65/wr/mm6521e1.htm (accessed October 12, 2016).
3. [3] Centers for Disease Control, National Notifiable Diseases Surveillance System, www.cdc.gov. https://wwwn.cdc.gov/nndss/conditions/zika/case-definition/2016/06/, 2016 (accessed October 12, 2016).
4. [4] World Health Organization, WHO Director-General summarizes the outcome of the Emergency Committee regarding clusters of microcephaly and Guillain-Barré syndrome, www.who.int. http://www.who.int/mediacentre/news/statements/2016/emergency-committee-zika-microcephaly/en/, 2016 (accessed October 12, 2016).
5. [5] World Health Organization, Guillain-Barré syndrome - Brazil, www.who.int. http://www.who.int/csr/don/8-february-2016-gbs-brazil/en/, 2016 (accessed October 12, 2016).
6. [6] World Health Organization, Guillain-Barré syndrome - France - French Polynesia, www.who.int. http://www.who.int/csr/don/7-march-2016-gbs-french-polynesia/en/, 2016 (accessed October 12, 2016).
7. [7] Dos Santos, T., Rodriguez, A., Almiron, M., Sanhueza, A., Ramon, P., de Oliveira, W.K., et al. Zika virus and the Guillain-Barre syndrome - case series from seven countries. N. Engl. J. Med., 2016, 10.1056/NEJMc1609015.
8. [8] Pan American Health Organization, Regional Zika Epidemiological Update (Americas) October 6, 2016, www.paho.org. http://www.paho.org/hq/index.php?option=com_content&view=article&id=11599<emid=41691&lang=en, 2016 (accessed October 12, 2016).
9. [9] Mecharles, S., Herrmann, C., Poullain, P., Tran, T.-H., Deschamps, N., Mathon, G., et al. Acute myelitis due to Zika virus infection. Lancet, 387, 2016, 1481, 10.1016/S0140-6736(16)00644-9.
10. [10] Carteaux, G., Maquart, M., Bedet, A., Contou, D., Brugieres, P., Fourati, S., et al. Zika virus associated with meningoencephalitis. N. Engl. J. Med. 374 (2016), 1595–1596, 10.1056/NEJMc1602964.
11. [11] World Health Organization, Zika virus infection - Dominican Republic, www.who.int. http://www.who.int/csr/don/27-january-2016-zika-dominican-republic/en/, 2016 (accessed October 12, 2016).
12. [12] Pan American Health Organization, Geographic distribution of confirmed autochthonous cases of Zika virus (vector-borne transmission) in countries and territories of the Americas, 2015–2016, ais.paho.org. http://ais.paho.org/phip/viz/ed_zika_countrymap.asp, 2016 (accessed October 12, 2016).
13. [13] Pan American Health Organization, Zika-epidemiological report, www.paho.org. http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=35103&Itemid=270, 2016 (accessed October 12, 2016).
14. [14] NYCDOH, Reported cases of Zika in New York City as of 9/30/2016, www1.nyc.gov. https://www1.nyc.gov/site/doh/health/health-topics/zika-virus.page, 2016 (accessed October 12, 2016).
15. [15] Yuki, N., Hartung, H.-P., Guillain-Barre syndrome. N. Engl. J. Med. 366 (2012), 2294–2304, 10.1056/NEJMra1114525.
16. [16] Parra, B., Lizarazo, J., Jimenez-Arango, J.A., Zea-Vera, A.F., Gonzalez-Manrique, G., Vargas, J., et al. Guillain-Barre syndrome associated with Zika virus infection in Colombia. N. Engl. J. Med., 2016, 10.1056/NEJMoa1605564.
17. [17] NYSDOH, Health advisory: Zika virus update, www.health.ny.gov. https://www.health.ny.gov/diseases/zika_virus/docs/2016-07-29_zika_virus_update.pdf, 2016 (accessed October 12, 2016).
18. [18] Pan American Health Organization, Dengue: PAHO/WHO data, maps and statistics, www.paho.org. http://www.paho.org/hq/index.php?option=com_topics&view=readall&cid=3273&Itemid=40734&lang=en, 2017 (accessed February 9, 2017).